Wellington Management Group LLP increased its holdings of Jiangsu Hengrui Pharmaceuticals (01276) by 4.96 thousand shares, at an approximate price of HK$66.13 per share.
The latest data from the Hong Kong Stock Exchange shows that on March 11th, Wellington Management Group LLP increased its holding of CSPC Pharmaceutical Group Limited (01276) by 49,600 shares at a price of HK$66.1267 per share, with a total amount of approximately HK$3.2799 million.
The latest data from the Hong Kong Stock Exchange shows that on March 11, Wellington Management Group LLP increased its holdings of Jiangsu Hengrui Pharmaceuticals (01276) by 49,600 shares, with a price of 66.1267 Hong Kong dollars per share, totaling approximately 3.2799 million Hong Kong dollars. After the increase, the total number of shares held is approximately 23.244 million shares, with a shareholding ratio of 9.00%.
Related Articles
GENSCRIPT BIO (01548) releases annual financial results, with a net loss attributable to shareholders of 533 million USD, a year-on-year shift from profit to loss.
SINOPEC SEG (02386) releases annual results, with shareholders' profit of 1.798 billion yuan, a year-on-year decrease of 27.1%.
CITIC SEC: The impact of rising PET prices is controllable, and beverage companies are expected to reduce hedging costs.
GENSCRIPT BIO (01548) releases annual financial results, with a net loss attributable to shareholders of 533 million USD, a year-on-year shift from profit to loss.
SINOPEC SEG (02386) releases annual results, with shareholders' profit of 1.798 billion yuan, a year-on-year decrease of 27.1%.
CITIC SEC: The impact of rising PET prices is controllable, and beverage companies are expected to reduce hedging costs.
